Heidi Pelemans
About
Heidi Pelemans is a scholar working on Infectious Diseases, Virology and Molecular Biology.
According to data from OpenAlex, Heidi Pelemans has authored 17 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Virology and 4 papers in Molecular Biology. Recurrent topics in Heidi Pelemans's work include HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (14 papers) and Biochemical and Molecular Research (3 papers). Heidi Pelemans is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (14 papers) and Biochemical and Molecular Research (3 papers). Heidi Pelemans collaborates with scholars based in Belgium, Spain and United Kingdom. Heidi Pelemans's co-authors include Erik De Clercq, Robert Esnouf, Jan Balzarini, Jan Balzarini, Anna Karlsson, Jan Balzarini, María‐Jesús Pérez‐Pérez, Ana San‐Félix, Marı́a-José Camarasa and Jan Balzarini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Virology.
In The Last Decade
Heidi Pelemans
17 papers receiving 436 citations
Peers
Heidi Pelemans
Murty N. Arimilli United States
Jérôme Deval United States
Daniel Pauletti United States
T. J. MCQUADE United States
Kazuki Izumi Japan
Susan Cox Sweden
C.E. Nichols United Kingdom
Scott R. Budihas United States
Imma Clotet‐Codina Spain
Victor G. Kramer Canada
Citations per year, relative to Heidi Pelemans Heidi Pelemans (= 1×)
peers
Murty N. Arimilli
Countries citing papers authored by Heidi Pelemans
Since
Specialization
Citations
This map shows the geographic impact of Heidi Pelemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Pelemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Pelemans more than expected).
Fields of papers citing papers by Heidi Pelemans
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Heidi Pelemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Pelemans. The network helps show where Heidi Pelemans may publish in the future.
Co-authorship network of co-authors of Heidi Pelemans
This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Pelemans. A scholar is included among the top collaborators of Heidi Pelemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Pelemans. Heidi Pelemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Pelemans, Heidi, Abram Aertsen, Kristel Van Laethem, et al.. (2001). Site-Directed Mutagenesis of Human Immunodeficiency Virus Type 1 Reverse Transcriptase at Amino Acid Position 138. Virology. 280(1). 97–106.
2.
Pelemans, Heidi, Robert Esnouf, Kyung‐Lyum Min, et al.. (2001). Mutations at Amino Acid Positions 63, 189, and 396 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) Partially Restore the DNA Polymerase Activity of a TRP229TYR Mutant RT. Virology. 287(1). 143–150.
3.
Rodrı́guez-Barrios, Fátima, Carlos A. Perez, Sonsoles Velázquez, et al.. (2001). Identification of a Putative Binding Site for [2‘,5‘-Bis-O-(tert-butyldimethylsilyl)-β-d -ribofuranosyl]-3‘-spiro-5‘ ‘-(4‘ ‘-amino-1‘ ‘,2‘ ‘-oxathiole-2‘ ‘,2‘ ‘-dioxide)thymine (TSAO) Derivatives at the p51−p66 Interface of HIV-1 Reverse Transcriptase. Journal of Medicinal Chemistry. 44(12). 1853–1865.
4.
Laethem, Kristel Van, Jean‐Claude Schmit, Heidi Pelemans, et al.. (2000). Presence of 2' ,5'-Bis- O -( tert -butyldimethylsilyl)-3-spiro-5"(4"-amino-1",2"-oxathiole-2",2"-dioxide) (TSAO)-Resistant Virus Strains in TSAO-Inexperienced HIV Patients. AIDS Research and Human Retroviruses. 16(9). 825–833.
5.
Pelemans, Heidi, Robert Esnouf, Erik De Clercq, & Jan Balzarini. (2000). Mutational Analysis of Trp-229 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) Identifies This Amino Acid Residue as a Prime Target for the Rational Design of New Non-Nucleoside RT Inhibitors. Molecular Pharmacology. 57(5). 954–960.
6.
Balzarini, Jan, et al.. (1998). Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-Dihydroquinoxaline-2(1H)-Thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined presence of quinoxaline HBY 097 and 2′,3′-dideoxy-3′-thiacytidine (Lamivudine). Biochemical Pharmacology. 55(5). 617–625.
7.
Pelemans, Heidi, Robert Esnouf, Heidi Jonckheere, Erik De Clercq, & Jan Balzarini. (1998). Mutational Analysis of Tyr-318 within the Non-nucleoside Reverse Transcriptase Inhibitor Binding Pocket of Human Immunodeficiency Virus Type I Reverse Transcriptase. Journal of Biological Chemistry. 273(51). 34234–34239.
8.
Pelemans, Heidi, Erik De Clercq, Jan Balzarini, et al.. (1998). A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152.. Journal of General Virology. 79(6). 1347–1352.
9.
Balzarini, Jan, Heidi Pelemans, Robert Esnouf, & Erik De Clercq. (1998). Short Communication : A Novel Mutation (F227L) Arises in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 on Dose-Escalating Treatment of HIV Type 1-Infected Cell Cultures with the Nonnucleoside Reverse Transcriptase Inhibitor Thiocarboxanilide UC-781. AIDS Research and Human Retroviruses. 14(3). 255–260.
10.
Balzarini, Jan, Heidi Pelemans, G Riess, et al.. (1997). Zidovudine‐Resistant Human Immunodeficiency Virus Type 1 Strains Subcultured in the Presence of Both Lamivudine and Quinoxaline HBY 097 Retain Marked Sensitivity to HBY 097 but Not to Lamivudine. The Journal of Infectious Diseases. 176(5). 1392–1397.
11.
Pelemans, Heidi, Robert Esnouf, Michael A. Parniak, et al.. (1997). Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1. Journal of Virology. 71(11). 8195–8203.
12.
Balzarini, Jan, J. Kruining, Heidi Pelemans, et al.. (1996). Anti-HIV and Anti-HBV Activity and Resistance Profile of 2′,3′-Dideoxy-3′-Thiacytidine (3TC) and Its Arylphosphoramidate Derivative CF 1109. Biochemical and Biophysical Research Communications. 225(2). 363–369.
13.
Balzarini, Jan, Heidi Pelemans, Stefano Aquaro, et al.. (1996). Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.. Molecular Pharmacology. 50(2). 394–401.
14.
Balzarini, Jan, Heidi Pelemans, María‐Jesús Pérez‐Pérez, et al.. (1996). Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.. Molecular Pharmacology. 49(5). 882–890.
15.
Balzarini, Jan, Heidi Pelemans, Anna Karlsson, Erik De Clercq, & Jőrg‐Peter Kleim. (1996). Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitors. Proceedings of the National Academy of Sciences. 93(23). 13152–13157.
16.
Michiels, Jan, et al.. (1994). Characterization of the Rhizobium leguminosarum biovar phaseoli nifA gene, a positive regulator of nif gene expression. Archives of Microbiology. 161(5). 404–408.
17.
Michiels, Jan, et al.. (1994). Characterization of the Rhizobium leguminosarum biovar phaseoli nifA gene, a positive regulator of nif gene expression. Archives of Microbiology. 161(5). 404–408.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Murty N. Arimilli Breakdown of academic impact, for papers by Jérôme Deval Breakdown of academic impact, for papers by Daniel Pauletti Breakdown of academic impact, for papers by T. J. MCQUADE Breakdown of academic impact, for papers by Kazuki Izumi Breakdown of academic impact, for papers by Susan Cox Breakdown of academic impact, for papers by C.E. Nichols Breakdown of academic impact, for papers by Scott R. Budihas Breakdown of academic impact, for papers by Imma Clotet‐Codina Breakdown of academic impact, for papers by Victor G. Kramer